Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

HilleVax, Inc. - Common Stock (NQ:HLVX)

2.090 UNCHANGED
Last Price Updated: 4:00 PM EDT, Sep 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about HilleVax, Inc. - Common Stock

< Previous 1 2 3 Next >
News headline image
XOMA Royalty Announces Closing of Tender Offer for HilleVax, Inc.
HilleVax Stockholders Received $1.95 Per Share in Cash Plus a Contingent Value Right 
From XOMA Royalty Corporation
Via GlobeNewswire
News headline image
HILLEVAX INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of HilleVax, Inc. - HLVX
From Kahn Swick & Foti, LLC
Via GlobeNewswire
News headline image
(HLVX) - Analyzing HilleVax's Short Interest ↗
 
Via Benzinga
News headline image
Shareholder Alert: The Ademi Firm Investigates Whether HilleVax, Inc. Is Obtaining a Fair Price for Its Public Shareholders
From Ademi & Fruchter LLP
Via Business Wire
News headline image
HilleVax Reports Second Quarter 2025 Financial Results
From HilleVax, Inc.
Via GlobeNewswire
News headline image
Unusual volume stocks are being observed in Wednesday's session. ↗
The trading volume of these stocks is deviating from the norm in today's session. 
Via Chartmill
News headline image
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SCS, HLVX, BSGM, TTNP on Behalf of Shareholders
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
HILLEVAX INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of HilleVax, Inc. - HLVX
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: HilleVax, Inc. (Nasdaq – HLVX), Steelcase Inc. (NYSE – SCS), LAVA Therapeutics N.V. (Nasdaq – LVTX), Arcadia Biosciences, Inc. (Nasdaq – RKDA)
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
HLVX Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of HilleVax, Inc. Is Fair to Shareholders
From Halper Sadeh LLC
Via Business Wire
News headline image
Kosmos Energy Posts Downbeat Q2 Results, Joins HilleVax And Other Big Stocks Moving Lower In Monday's Pre-Market Session ↗
 
Via Benzinga
News headline image
HilleVax Enters into a Definitive Agreement to be Acquired by XOMA Royalty for $1.95 in Cash per Share Plus a Contingent Value Right
From XOMA Royalty Corporation
Via GlobeNewswire
News headline image
12 Health Care Stocks Moving In Tuesday's After-Market Session ↗
 
Via Benzinga
News headline image
HilleVax Reports First Quarter 2025 Financial Results and Highlights Recent Company Progress
From HilleVax, Inc.
Via GlobeNewswire
News headline image
HilleVax Reports Full Year 2024 Financial Results and Highlights Recent Company Progress
From HilleVax, Inc.
Via GlobeNewswire
News headline image
HilleVax Reports Third Quarter 2024 Financial Results and Highlights Recent Company Progress
From HilleVax, Inc.
Via GlobeNewswire
News headline image
HLVX Stock Earnings: HilleVax Misses EPS for Q2 2024 ↗
HLVX stock results show that HilleVax missed analyst estimates for earnings per share the second quarter of 2024. 
Via InvestorPlace
News headline image
HilleVax Reports Second Quarter 2024 Financial Results and Highlights Recent Company Progress
From HilleVax, Inc.
Via GlobeNewswire
News headline image
HilleVax Announces Reduction in Force
From HilleVax, Inc.
Via GlobeNewswire
News headline image
HilleVax, Inc. (HLVX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
News headline image
HilleVax, Inc. (HLVX) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
From Bronstein, Gewirtz & Grossman, LLC
Via Business Wire
News headline image
Gold Falls Over 1%; HilleVax Shares Plunge ↗
 
Via Benzinga
News headline image
Stocks Hold Steady, Small Caps Rise, French Equities Slip After Surprise Win By Left-Wing Bloc: What's Driving Markets Monday? ↗
U.S. stocks started the week on a neutral note, with the S&P 500 and Nasdaq 100 indices hovering around the flatline by midday trading in New York. This comes after both indices reached fresh record... 
Via Benzinga
News headline image
Why Arhaus Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗
 
Via Benzinga
News headline image
GRFS Stock Alert: Grifols Pops 20% on Takeover Interest ↗
Grifols stock is up on Monday as the founding family of the company has presented a preliminary takeover offer for GRFS shares. 
Via InvestorPlace
News headline image
Why Is HilleVax (HLVX) Stock Down 87% Today? ↗
HilleVax stock is down on Monday after HLVX investors learned of a failed Phase 2b clinical trial of its norovirus vaccine for infants. 
Via InvestorPlace
News headline image
HLVX Investors Have Opportunity to Join HilleVax, Inc. Securities Fraud Investigation with the Schall Law Firm
From The Schall Law Firm
Via Business Wire
News headline image
Dow Turns Lower; Myomo Shares Jump ↗
 
Via Benzinga
Topics Stocks
News headline image
Dow Jumps Over 200 Points; Greenbrier Shares Fall After Q3 Results ↗
 
Via Benzinga
Topics Stocks
News headline image
Vaccine Developer HilleVax Stock Nosedives On Monday - Here's Why ↗
Shares of HilleVax fell after the release of Phase 2b trial results for HIL-214, a vaccine for norovirus-related acute gastroenteritis in infants. The study showed 5% efficacy and no significant... 
Via Benzinga
< Previous 1 2 3 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.